Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178 Results filed 28 Oct 2026

What the insiders did Net selling

By person

21 insiders · 163 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mihael Hristos Polymeropoulos
President and CEO
$504.86K (14)
$21.77M (34) scheduled
−$21.26M
2,704,496
4.47%
$10.29M
+212.6%
Gunther Birznieks
SVP, Business Development
—
$2.02M (19)
−$2.02M
494,197
0.8174%
$1.88M
+289.3%
Timothy Williams
SVP & General Counsel
—
$1.55M (19)
−$1.55M
377,450
0.6243%
$1.44M
—
Aranthan Jones II
Chief Corp. Affairs Officer
—
$1.43M (7) scheduled
−$1.43M
81,980
0.1356%
$311.87K
+36.6%
James Patrick Kelly
EVP & Chief Financial Officer
—
$1.16M (11)
−$1.16M
186,869
0.3091%
$710.89K
+131.4%
Kevin Patrick Moran
SVP, CFO & Treasurer
$8.78K (1)
$1.06M (16)
−$1.05M
412,015
0.6814%
$1.57M
+571.2%
Joakim Wijkstrom
SVP, Chief Marketing Officer
—
$706.47K (11)
−$706.47K
333,469
0.5515%
$1.27M
—
Stephen Ray Mitchell
Director
—
$540.03K (6) scheduled
−$540.03K
112,846
0.1866%
$429.29K
+56,323%
Richard W Dugan
Director
—
$505.27K (4) scheduled
−$505.27K
219,054
0.3623%
$833.33K
+3,696%
Richard L. Gulino
SVP, General Counsel & Sec.
—
$395.13K (3) scheduled
−$395.13K
115,073
0.1903%
$437.76K
+187.7%
Thomas Watkins
Director
—
$282.92K (3) scheduled
−$282.92K
63,064
0.1043%
$239.91K
—
Paolo Baroldi
SVP & Chief Medical Officer
—
$252.78K (1) scheduled
−$252.78K
54,365
0.0899%
$206.82K
+574.1%
Tage Honore
Director
—
$240.90K (1)
−$240.90K
135,069
0.2234%
$513.83K
—
Gian Piero Reverberi
SVP & Chief Commercial Officer
—
$81.00K (6)
−$81.00K
165,384
0.2735%
$629.15K
+313.5%
Phaedra Chrousos
Director
—
$40.13K (1)
−$40.13K
164,950
0.2728%
$627.50K
—
Charles Cliff Duncan
Director
$38.09K (3)
—
+$38.09K
108,701
0.1798%
$413.52K
—
Anne Sempowski Ward
Director
—
—
—
160,667
0.2657%
$611.21K
—
Daniel Patrick McGuire
SVP, GC and Secretary
—
—
—
109,982
0.1819%
$418.39K
+266.8%
Michael F Cola
Director
—
—
—
15,000
0.0248%
$57.06K
—
Vincent Milano
Director
—
—
—
10,000
0.0165%
$38.04K
—
Kenneth Bate
Director
—
—
—
5,000
0.0083%
$19.02K
—